Hypomyelinating Leukodystrophy 6 C2676244
A rare genetic disorder that prevents normal development of myelin, the protective coating around brain nerves. It primarily affects children and causes progressive movement problems, developmental delays, and speech difficulties. Treatment focuses on managing symptoms and supporting mobility through physical and occupational therapy.
Key facts at a glance
- ICD-10
- G40.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(neurologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Motor developmental delay
(neurologic)Spasticity
(neurologic)Cerebellar ataxia
(neurologic)Peripheral neuropathy
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Neurodevelopmental assessment
Regular developmental and neurological evaluations to monitor motor skills, cognition, and overall disease progression in pediatric patients.
Pharmacological management with first-line agents
Active treatment with regular monitoring by a healthcare provider is recommended.
Comprehensive rehabilitation program
Multi-disciplinary rehabilitation including physical therapy, occupational therapy, and speech therapy as needed to address motor and functional limitations.
Additional treatment options
Dystonia and movement disorder management
Medications to address dystonia and involuntary movements when present, potentially including anticholinergics or other agents targeting specific symptoms.
medicationNeuroimaging with advanced sequences
MRI with specialized sequences to better characterize myelin pathology and white matter involvement for diagnostic confirmation and monitoring.
procedureFamily education and support services
Comprehensive education for caregivers and families about disease progression, care needs, and access to support resources and genetic counseling.
lifestyleWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Hypomyelinating Leukodystrophy 6 C2676244?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Hypomyelinating Leukodystrophy 6 C2676244. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy